Glp-1 receptor agonists in kidney transplant recipients with type 2 diabetes mellitus: a systematic review and meta-analysis on mortality and major adverse kidney events
View pricing & enrol Who this training is for You are a qualified or training practitioner who wants stronger glutathione intramuscular injection online theory before practical progression
Current and Emerging Medications: Name Type Status Tirzepatide Dual GLP-1 / GIP Agonist FDA Approved CagriSema Dual GLP-1 / Amylin AgonistIn Phase 3 Trials Retatrutide Triple GIP / GLP-1 / GlucagonIn Phase 3 Trials These multi-pathway drugs aim to improve results but may also come with more side effects
About Titan Biotech Limited Titan Biotech, based in Delhi, India, specializes in supplying top-quality raw materials to diverse industries such as pharmaceuticals, nutraceuticals, cosmeceuticals, and the food and beverage sector
Ethical Approval This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors